Notice: ASA extends its thoughts and condolences to those affected by the disaster in Oklahoma. Donations to help aid this relief can be made through the American Red Cross website.

>

WEBINARS

RSS
>

MEETINGS / EVENTS

RSS
>

FDA MEDWATCH ALERTS

RSS

May 20, 2013

All Sterile Drug Products Made and Distributed By NuVision Pharmacy Dallas Facility: Recall - Lack Of Sterility Assurance

Summary:

All Sterile Drug Products Made and Distributed By NuVision Pharmacy Dallas Facility

May 14, 2013

Zolpidem Containing Products: Drug Safety Communication - FDA Requires Lower Recommended Doses

Summary:

Zolpidem Containing Products Drug Safety Communication

May 09, 2013

The Compounding Shop: FDA News Release - Lack of Sterility Assurance of Drug Products

Summary:

The Compounding Shop FDA News Release Lack of Sterility

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Anesthesiology Continuing Education (ACE) Program

SKU: 30702-13CE

... Read more »

Single Copies, Member Price: $360

ASA Responds to Release of GAO Drug Shortage Report

Friday, December 16, 2011

Recently, the Government Accountability Office (GAO) released a long-awaited report on the crisis of drug shortages.  The report is in response to continuing problems that anesthesiologists and other physicians face as they confront an unprecedented number of drug shortages.

ASA President Jerry Cohen, M.D. offered the following remarks about the report’s release:

“ASA was pleased by the release of the GAO Drug Shortages report and appreciated the opportunity to participate as an expert resource in the production of the report. As anesthesiologists continue to confront unprecedented drug shortages across the country, ASA is proud of our efforts in coordination with members of the Drug Shortage Summit to successfully elevate this critical issue in both Congress and the Administration.  We look forward to thoroughly reviewing the GAO report and its recommendations.”

« Back to Washington Alerts